跳至主要内容
临床试验/NCT02730468
NCT02730468已完成不适用

SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay

Karius, Inc.1 个研究点 分布在 1 个国家目标入组 350 人开始时间: 2016年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Karius, Inc.
入组人数
350
试验地点
1
主要终点
Accuracy of sequencing assay in diagnosing etiology of sepsis

研究概览

简要总结

The purpose of this study is to evaluate the performance of the Karius Infectious Diseases Plasma Sequencing Assay in patients who present to the emergency room with sepsis.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years or older
  • Meet 2 of 4 sepsis criteria
  • Temperature > 38C or < 36C
  • Heart rate > 90 bpm
  • Respiratory rate >20 or PaCO2 <32mmHg
  • WBC >12000/µL or < 4000/µL or > 10% bands

排除标准

  • Inability to understand instructions and comply with study-related procedures
  • Any condition that in the opinion of the treating physician will prevent the subject from completing the study.

结局指标

主要结局

Accuracy of sequencing assay in diagnosing etiology of sepsis

时间窗: 7 days

次要结局

未报告次要终点

研究者

发起方
Karius, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

SEP-SEQ Trial - Determining the Etiology of Sepsis... | 临床试验